Insider Trading & Ownership of Innoviva, Inc.

Location
Burlingame, CA
Summary
The estimated value of insider holdings of Innoviva, Inc. is at least $345,222,079 dollars as of 12 Jan 2023. Innoviva, Inc. is the Director, 10%+ Owner of Armata Pharmaceuticals, Inc. and owns shares of Armata Pharmaceuticals, Inc. (ARMP) stock worth about $182.4M. Innoviva, Inc. is the 10%+ Owner of Entasis Therapeutics Holdings Inc. and owns shares of Entasis Therapeutics Holdings Inc. stock worth about $162.82M.
Signature
INNOVIVA, INC. By: /s/ Pavel Raifeld Name: Pavel Raifeld Title: Chief Executive Officer
All Insider Reports
All Insider Reports

Notify me when Innoviva, Inc. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Innoviva, Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARMP Armata Pharmaceuticals, Inc. Director, 10%+ Owner $182,400,865 10 Jan 2023
ETTX Entasis Therapeutics Holdings Inc. 10%+ Owner $162,821,214 08 Jul 2022

Insider Transactions Reported by Innoviva, Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.